Invasive Aspergillosis in Patients with Acute Leukemia: Update on Morbidity and Mortality--SEIFEM-C Report
Open Access
- 1 June 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 44 (11) , 1524-1525
- https://doi.org/10.1086/517849
Abstract
To the Editor—Aspergillus species represent the main cause of fungal infections in patients with acute leukemia [1, 2]. During the past few years, we have conduKeywords
This publication has 9 references indexed in Scilit:
- Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)Clinical Infectious Diseases, 2007
- Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with NeutropeniaNew England Journal of Medicine, 2007
- Cutaneous phaeohyphomycosis caused byCladosporium oxysporumand its treatment with potassium iodideMedical Mycology, 2006
- Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility StudyClinical Infectious Diseases, 2005
- Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignanciesEuropean Journal of Haematology, 2005
- Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal TherapyClinical Infectious Diseases, 2004
- Refractory Aspergillus pneumonia in patients with acute leukemiaCancer, 2003
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Invasive Aspergillosis Disease Spectrum, Treatment Practices, and OutcomesMedicine, 2000